Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy

European Journal of Heart Failure

Volumn 11, Issue 6, 2009, Pages 573-580

  Choi, Eui Young ^a   Choi, Byoung Wook ^b   Kim, Sung Ai ^a   Rhee, Sang Jae ^a   Shim, Chi Young ^a   Kim, Young Jin ^b   Kang, Seok Min ^a   Ha, Jong Won ^a   Chung, Namsik ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Dilated cardiomyopathy; Magnetic resonance imaging; Ventricular elastance

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTERY COMPLIANCE; CLINICAL ARTICLE; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ELASTICITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE COMPLIANCE; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE FILLING; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RIGIDITY; SYSTOLE; SYSTOLIC HEART FAILURE;

CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 68949107342     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp050     Document Type: Conference Paper

References (26)

1. Thohan V. Prognostic implications of echocardiography in advanced heart failure. Curr Opin Cardiol 2004;19:238-249.
2. Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, Plehn JF, Rahko P, St John Sutton M, Eichhorn EJ, BEST Trial Echocardiographic Substudy Investigators. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure. The beta-blocker evaluation of survival trial (BEST). J Am Coll Cardiol 2005;45:1064-1071.
3. Neumann T, Vollmer A, Schaffner T, Hess OM, Heusch G. Diastolic dysfunction and collagen structure in canine pacing-induced heart failure. J Mol Cell Cardiol 1999;31:179-192.
4. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res 1998;82:482-495.
5. Asanoi H, Kameyama T, Ishizaka S, Nozawa T, Inoue H. Energetically optimal left ventricular pressure for the failing human heart. Circulation 1996;93:67-73.
6. Ishihara H, Yokota M, Sobue T, Saito H. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;23:406- 416.
7. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota. Circulation 2007;115:1982-1990.
8. Garcia-Bolao I, Macias A, Lopez B, Gonzalez A, Gavira JJ, Azearate P, Alegría E, Díez J. A Biomarker of myocardial fibrosis predicts long-term response to cardiac resynchronization therapy. J Am Coll Cardiol 2006;47:2335-2337.
9. Kass DA, Spragg DD. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis 2006;49;:26-41.
10. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-1985.
11. McCrohon JA, Monn JCC, Prasad SK, Mckenna WJ, Lorenz CH, Coats AJS, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59.
12. Park S, Choi B, Rim S, Shim CY, Ko YG, Kang SM, Ha JW, Jang Y, Chung N, Choe KO, Cho SY. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction. J Card Fail 2006;12:93-99.
13. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
15. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age- and gender-related ventricular-vascular stiffening. A community-based study. Circulation 2005; 112:2254-2262.
16. Ha JW, Lee HC, Park S, Choi EY, Seo HS, Shim CY, Kim JM, Ahn JA, Lee SW, Rim SJ, Oh JK, Chung N. Gender-related difference in left ventricular diastolic elastance during exercise in patients with diabetes mellitus. Circ J 2008;72: 1443-1448.
17. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992;86:513-521.
18. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, Kawaguchi M, Kass DA. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001;38:2028-2034.
19. Bauer F, Jones M, Shiota T, Firstenberg MS, Qin JX, Tsujino H, Kim YJ, Sitges M, Cardon LA, Zetts AD, Thomas JD. Left ventricular outflow tract mean systolic acceleration as a surrogate for the slope of the left ventricular end-systolic pressure-volume relationship. J Am Coll Cardiol 2002;40:1320-1327.
20. Mahrholdt H,Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-1474.
21. Zile M, Brutsaert D. New concepts in diastolic dysfunction and diastolic heart failure: part II. Casual mechanisms and treatment. Circulation 2002;105:1503-1508.
22. Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 2005;112:2940-2945.
23. Ryoke T, Gu Y, Mao L, Hongo M, Clark RG, Peterson KL, Ross J Jr. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. Circulation 1999; 100:1734-1743.
24. MacKenna DA, Omens JH, MuCulloch AD, Covell JW. Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am J Physiol 1994;266:H1007-H1018.
25. Shmuylovich L, Kovacs S. Load-independent index of diastolic filling: model-based derivation with in vivo validation in control and diastolic dysfunction subjects. J Appl Physiol 2006;101:92-101.
26. Ugander M, Ekmehag B, Arheden H. The relationship between left ventricular ejection fraction and infarct size assessed by MRI. Scand Cardiovasc J 2008;42: 137-145.